NEW YORK, Nov. 20, 2015 /PRNewswire/ -- According to Kalorama Information, Roche has continued to dominate the in vitro diagnostic (IVD) market in 2015, gaining greater access to new segments of the market along the way. Roche has maintained its position as the world's largest supplier of clinical diagnostics products, with product sales still almost twice of its nearest competitor. The healthcare market researcher's report, Roche Diagnostics: Company Profile, examines the Swiss global research-based healthcare company.
Roche Diagnostics: Company Profile can be found at Kalorama Information: http://www.kaloramainformation.com/redirect.asp?progid=88058&productid=9383834.
Business areas in Roche's diagnostics division include professional diagnostics, diabetes care, molecular diagnostics, and tissue diagnostics.
Roche professional diagnostics products support clinical decision making in a wide variety of indication fields including oncology, virology, cardiovascular, inflammatory and infectious diseases. Roche professional diagnostics provide solutions for blood serum testing in central laboratories such as commercial and hospital labs. In addition, Roche professional diagnostics markets products designed for the professional point-of-care market.
Roche is a frontrunner in diabetes management. Roche launched the new cobas c 513 analyzer in October 2015. One of the main features of the cobas c 513 analyzer includes HbA1c testing for risk identification, diagnosis, and monitoring of people with diabetes. This new high-throughput HbA1c testing solution is now available for countries accepting the CE mark.
Roche molecular diagnostics offers assays in the areas of infectious diseases (including both diagnostic and blood screening products), genomics and oncology. Roche molecular diagnostics also offers PCR-based assays for detection of cancer gene mutations in formalin-fixed, paraffin-embedded tissue (FFPET).
Roche is the world leader in tissue-based cancer diagnostics. Roche had entered the tissue diagnostics field in 2008 with the acquisition of Ventana Medical Systems for approximately $3.4 billion.
Roche has also established a sequencing business within its diagnostics operating segment, and has recently been very active in making acquisitions and entering into collaborations in next-generation sequencing. Roche in August 2015 acquired Kapa Biosystems, a provider of genomic tools in the life sciences sector that employs proprietary technologies to optimize enzymes for next-generation sequencing (NGS). In April of this year, Roche entered into a strategic collaboration with Foundation Medicine. Roche also acquired Signature Diagnostics AG in February 2015 and Bina Technologies in December 2014.
To help maintain its dominance in IVD, Roche has continued in 2015 to expand geographically with special emphasis on markets in the top seven emerging countries: Brazil, Russia, India, China, South Korea, Mexico and Turkey.
The information presented in Roche Diagnostics: Company Profile is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.
Roche Diagnostics: Company Profile can be found at Kalorama Information: http://www.kaloramainformation.com/redirect.asp?progid=88058&productid=9383834.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.
We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.
Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com
Logo - http://photos.prnewswire.com/prnh/20140801/132634
SOURCE Kalorama Information
Related Links
http://www.KaloramaInformation.com
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article